FDA approves gene therapy for sickle cell disease in children as young as 2 years old

FDA approves gene therapy for sickle cell disease in children as young as 2 years old
FacebookXWhatsAppEmail

The Food and Drug Administration has approved a gene therapy that can eliminate complications from sickle cell disease in children as young as 2 years old, expanding access to a treatment previously limited to patients 12 and older.Rickey Buggs, 13, is among the first patients to receive the trea...